Skip to main content
Erschienen in: Urolithiasis 3/2020

10.09.2019 | Original Paper

Idiopathic calcium nephrolithiasis with pure calcium oxalate composition: clinical correlates of the calcium oxalate dihydrate/monohydrate (COD/COM) stone ratio

verfasst von: Angela Guerra, Andrea Ticinesi, Franca Allegri, Silvana Pinelli, Rosalia Aloe, Tiziana Meschi

Erschienen in: Urolithiasis | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Pure calcium oxalate is the most frequent type of idiopathic kidney stone composition. Fourier transform infrared spectroscopy (FT-IR) allows to detect the ratio of calcium oxalate dihydrate (COD) and monohydrate (COM) crystals in stones, but the clinical significance of this parameter remains uncertain. The objective of this observational study was to verify the association of clinical and laboratory parameters of kidney stone disease with COD/COM ratio in a group of 465 (322 M, age 46 ± 14) patients suffering from idiopathic calcium nephrolithiasis with pure calcium oxalate stones (≥ 97%). Each participant underwent a complete clinical examination, serum chemistry, 24-h urine collection for the determination of the profile of lithogenic risk, and had stones analyzed by FT-IR. Most (62%) of the stones had a COD/COM ratio ≤ 0.25, and the urine chemistry of the corresponding patients showed a low prevalence of urinary metabolic abnormalities. With increasing COD/COM ratio intervals (0–0.25, 0.26–0.50, 0.51–0.75, 0.76–1), a significant association was observed for the number of urological procedures, serum calcium, 24-h urinary calcium excretion, prevalence of hypercalciuria and relative calcium oxalate supersaturation, and a negative trend was detected for the age of the first stone episode (all p values < 0.05). A linear regression model showed that the only parameters significantly associated with COD/COM ratio were 24-h urinary calcium excretion (standardized β = 0.464, p < 0.001) and urine pH (standardized β = 0.103, p = 0.013). In pure calcium oxalate idiopathic stones, COD/COM ratio may reflect the presence of urinary metabolic risk factors, and represent a guide for the prescription of urinary analyses.
Literatur
1.
Zurück zum Zitat Romero V, Akpinar H, Assimos DG (2010) Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 12(2–3):e86–e96PubMedPubMedCentral Romero V, Akpinar H, Assimos DG (2010) Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 12(2–3):e86–e96PubMedPubMedCentral
2.
Zurück zum Zitat Daudon M, Réveillaud RJ (1984) Whewellite and weddellite: toward a different etiopathogenesis. Nephrologie 5(5):195–201PubMed Daudon M, Réveillaud RJ (1984) Whewellite and weddellite: toward a different etiopathogenesis. Nephrologie 5(5):195–201PubMed
3.
Zurück zum Zitat Daudon M, Bader CA, Jungers P (1993) Urinary calculi: review of classification methods and correlations with etiology. Scan Microsc 7(3):1081–1106 Daudon M, Bader CA, Jungers P (1993) Urinary calculi: review of classification methods and correlations with etiology. Scan Microsc 7(3):1081–1106
4.
Zurück zum Zitat Jiang D, Geng H (2017) Primary hyperoxaluria. N Engl J Med 376(15):e33CrossRef Jiang D, Geng H (2017) Primary hyperoxaluria. N Engl J Med 376(15):e33CrossRef
5.
Zurück zum Zitat Daudon M, Jungers P, Bazin D (2008) Peculiar morphology of stones in primary hyperoxaluria. N Engl J Med 359(1):100–102CrossRef Daudon M, Jungers P, Bazin D (2008) Peculiar morphology of stones in primary hyperoxaluria. N Engl J Med 359(1):100–102CrossRef
6.
Zurück zum Zitat Sutton RA, Walker VR (1994) Enteric and mild hyperoxaluria. Miner Electrolyte Metab 20(6):352–360PubMed Sutton RA, Walker VR (1994) Enteric and mild hyperoxaluria. Miner Electrolyte Metab 20(6):352–360PubMed
7.
Zurück zum Zitat Massey LK, Liebman M, Kynast-Gales SA (2005) Ascorbate increases human oxaluria and kidney stone risk. J Nutr 135(7):1673–1677CrossRef Massey LK, Liebman M, Kynast-Gales SA (2005) Ascorbate increases human oxaluria and kidney stone risk. J Nutr 135(7):1673–1677CrossRef
8.
Zurück zum Zitat Albert A, Tiwari V, Paul E, Ponnusamy S, Ganesan D, Prabhakaran R et al (2018) Oral administration of oxalate-enriched spinach extract as an improved methodology for the induction of dietary hyperoxaluric nephrocalcinosis in experimental rats. Toxicol Mech Methods 28(3):195–204CrossRef Albert A, Tiwari V, Paul E, Ponnusamy S, Ganesan D, Prabhakaran R et al (2018) Oral administration of oxalate-enriched spinach extract as an improved methodology for the induction of dietary hyperoxaluric nephrocalcinosis in experimental rats. Toxicol Mech Methods 28(3):195–204CrossRef
9.
Zurück zum Zitat Daudon M, Bazin D, André G, Jungers P, Cousson A, Chevallier P et al (2009) Examination of whewellite kidney stones by scanning electron microscopy and powder neutron diffraction techniques. J Appl Cryst 42:109–115CrossRef Daudon M, Bazin D, André G, Jungers P, Cousson A, Chevallier P et al (2009) Examination of whewellite kidney stones by scanning electron microscopy and powder neutron diffraction techniques. J Appl Cryst 42:109–115CrossRef
10.
Zurück zum Zitat Park S, Pearle MS (2007) Pathophysiology and management of calcium stones. Urol Clin N Am 34(3):323–334CrossRef Park S, Pearle MS (2007) Pathophysiology and management of calcium stones. Urol Clin N Am 34(3):323–334CrossRef
11.
Zurück zum Zitat Prezioso D, Strazzullo D, Lotti T, Bianchi G, Borghi L, Caione P et al (2015) Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Arch Ital Urol Androl 87(2):105–120CrossRef Prezioso D, Strazzullo D, Lotti T, Bianchi G, Borghi L, Caione P et al (2015) Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Arch Ital Urol Androl 87(2):105–120CrossRef
12.
Zurück zum Zitat Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E et al (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29(6):715–734CrossRef Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E et al (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29(6):715–734CrossRef
13.
Zurück zum Zitat Nouvenne A, Ticinesi A, Allegri F, Guerra A, Guida L, Morelli I et al (2014) Twenty-five years of idiopathic calcium nephrolithiasis: has anything changed? Clin Chem Lab Med 52(3):337–344CrossRef Nouvenne A, Ticinesi A, Allegri F, Guerra A, Guida L, Morelli I et al (2014) Twenty-five years of idiopathic calcium nephrolithiasis: has anything changed? Clin Chem Lab Med 52(3):337–344CrossRef
14.
Zurück zum Zitat Guerra A, Folesani G, Nouvenne A, Ticinesi A, Allegri F, Pinelli S et al (2016) Family history influences clinical course of idiopathic calcium nephrolithiasis: case–control study of a large cohort of Italian patients. J Nephrol 29(5):645–651CrossRef Guerra A, Folesani G, Nouvenne A, Ticinesi A, Allegri F, Pinelli S et al (2016) Family history influences clinical course of idiopathic calcium nephrolithiasis: case–control study of a large cohort of Italian patients. J Nephrol 29(5):645–651CrossRef
15.
Zurück zum Zitat Ticinesi A, Guerra A, Allegri F, Nouvenne A, Cervellin G, Maggio M et al (2018) Determinants of calcium and oxalate excretion in subjects with calcium nephrolithiasis: the role of metabolic syndrome traits. J Nephrol 31(3):395–403CrossRef Ticinesi A, Guerra A, Allegri F, Nouvenne A, Cervellin G, Maggio M et al (2018) Determinants of calcium and oxalate excretion in subjects with calcium nephrolithiasis: the role of metabolic syndrome traits. J Nephrol 31(3):395–403CrossRef
16.
Zurück zum Zitat Ferraro PM, Ticinesi A, Meschi T, Rodgers A, Di Maio F, Fulignati P et al (2018) Short-term changes in urinary supersaturation predict recurrence of kidney stones: a tool to guide preventive measures in urolithiasis. J Urol 200(5):1082–1087CrossRef Ferraro PM, Ticinesi A, Meschi T, Rodgers A, Di Maio F, Fulignati P et al (2018) Short-term changes in urinary supersaturation predict recurrence of kidney stones: a tool to guide preventive measures in urolithiasis. J Urol 200(5):1082–1087CrossRef
17.
Zurück zum Zitat Werness P, Brown CM, Smith LH, Finlayson B (1985) Equil2: a basic computer program for the calculation of urinary saturation. J Urol 134:1242–1244CrossRef Werness P, Brown CM, Smith LH, Finlayson B (1985) Equil2: a basic computer program for the calculation of urinary saturation. J Urol 134:1242–1244CrossRef
18.
Zurück zum Zitat Maurice-Estepa L, Levillain P, Lacour B, Daudon M (2000) Advantage of zero-crossing-point first-derivative spectrophotometry for the quantification of calcium oxalate crystalline phases by infrared spectrophotometry. Clin Chim Acta 298(1–2):1–11CrossRef Maurice-Estepa L, Levillain P, Lacour B, Daudon M (2000) Advantage of zero-crossing-point first-derivative spectrophotometry for the quantification of calcium oxalate crystalline phases by infrared spectrophotometry. Clin Chim Acta 298(1–2):1–11CrossRef
19.
Zurück zum Zitat Castiglione V, Jouret F, Bruyère O, Dubois B, Thomas A, Waltregny D et al (2015) Epidemiology of urolithiasis in Belgium on the basis of a morpho-constitutional classification. Nephrol Ther 11(1):42–49CrossRef Castiglione V, Jouret F, Bruyère O, Dubois B, Thomas A, Waltregny D et al (2015) Epidemiology of urolithiasis in Belgium on the basis of a morpho-constitutional classification. Nephrol Ther 11(1):42–49CrossRef
20.
Zurück zum Zitat Daudon M, Traxer O, Lechevallier E, Saussine C (2008) Epidemiology of urolithiasis. Prog Urol 18(12):802–814CrossRef Daudon M, Traxer O, Lechevallier E, Saussine C (2008) Epidemiology of urolithiasis. Prog Urol 18(12):802–814CrossRef
21.
Zurück zum Zitat Pierratos AE, Khalaff H, Cheng PT, Psihramis K, Jewett MA (1994) Clinical and biochemical differences in patients with pure calcium oxalate monohydrate and calcium oxalate dehydrate kidney stones. J Urol 151(3):571–574CrossRef Pierratos AE, Khalaff H, Cheng PT, Psihramis K, Jewett MA (1994) Clinical and biochemical differences in patients with pure calcium oxalate monohydrate and calcium oxalate dehydrate kidney stones. J Urol 151(3):571–574CrossRef
22.
Zurück zum Zitat Parent X, Boess G, Brignon P (1999) Calcium oxalate lithiasis. Relationship between biochemical risk factors and crystalline phase of the stone. Prog Urol 9(6):1051–1056PubMed Parent X, Boess G, Brignon P (1999) Calcium oxalate lithiasis. Relationship between biochemical risk factors and crystalline phase of the stone. Prog Urol 9(6):1051–1056PubMed
23.
Zurück zum Zitat Asplin JR, Lingeman J, Kahnoski R, Mardis H, Parks JH, Coe FL (1998) Metabolic urinary correlates of calcium oxalate dehydrate in renal stones. J Urol 159(3):664–668CrossRef Asplin JR, Lingeman J, Kahnoski R, Mardis H, Parks JH, Coe FL (1998) Metabolic urinary correlates of calcium oxalate dehydrate in renal stones. J Urol 159(3):664–668CrossRef
24.
Zurück zum Zitat Daudon M, Letavernier E, Frochot V, Haymann JP, Bazin D, Jungers P (2016) Respective influence of calcium and oxalate urine concentration on the formation of calcium oxalate kidney monohydrate or dehydrate crystals. C R Chim 19:1504–1513CrossRef Daudon M, Letavernier E, Frochot V, Haymann JP, Bazin D, Jungers P (2016) Respective influence of calcium and oxalate urine concentration on the formation of calcium oxalate kidney monohydrate or dehydrate crystals. C R Chim 19:1504–1513CrossRef
25.
Zurück zum Zitat Manissorn J, Fong-Ngern K, Peerapen P, Thongboonkerd V (2017) Systematic evaluation for effects of urine pH on calcium oxalate crystallization, crystal-cell adhesion and internalization into renal tubular cells. Sci Rep 7(1):1798CrossRef Manissorn J, Fong-Ngern K, Peerapen P, Thongboonkerd V (2017) Systematic evaluation for effects of urine pH on calcium oxalate crystallization, crystal-cell adhesion and internalization into renal tubular cells. Sci Rep 7(1):1798CrossRef
26.
Zurück zum Zitat Parks JH, Coward M, Coe FL (1997) Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 51(3):894–900CrossRef Parks JH, Coward M, Coe FL (1997) Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 51(3):894–900CrossRef
27.
Zurück zum Zitat Singh P, Enders FT, Vaughan LE, Bergstralh EJ, Knoedler JJ, Krambeck AE et al (2015) Stone composition among first-time symptomatic kidney stone formers in the community. Mayo Clin Proc 90(10):1356–1365CrossRef Singh P, Enders FT, Vaughan LE, Bergstralh EJ, Knoedler JJ, Krambeck AE et al (2015) Stone composition among first-time symptomatic kidney stone formers in the community. Mayo Clin Proc 90(10):1356–1365CrossRef
28.
Zurück zum Zitat Vaughan LE, Enders FT, Lieske JC, Pais VM, Rivera ME, Mehta RA et al (2019) Predictors of symptomatic kidney stone recurrence after the first and subsequent episodes. Mayo Clin Proc 94(2):202–210CrossRef Vaughan LE, Enders FT, Lieske JC, Pais VM, Rivera ME, Mehta RA et al (2019) Predictors of symptomatic kidney stone recurrence after the first and subsequent episodes. Mayo Clin Proc 94(2):202–210CrossRef
29.
Zurück zum Zitat Ticinesi A, Nouvenne A, Borghi L, Meschi T (2017) Water and other fluids in nephrolithiasis: state of the art and future challenges. Crit Rev Food Sci Nutr 57(5):963–974CrossRef Ticinesi A, Nouvenne A, Borghi L, Meschi T (2017) Water and other fluids in nephrolithiasis: state of the art and future challenges. Crit Rev Food Sci Nutr 57(5):963–974CrossRef
30.
Zurück zum Zitat Ticinesi A, Nouvenne A, Maalouf NM, Borghi L, Meschi T (2016) Salt and nephrolithiasis. Nephrol Dial Transplant 31(1):39–45CrossRef Ticinesi A, Nouvenne A, Maalouf NM, Borghi L, Meschi T (2016) Salt and nephrolithiasis. Nephrol Dial Transplant 31(1):39–45CrossRef
31.
Zurück zum Zitat Guerra A, Ticinesi A, Allegri F, Nouvenne A, Prati B, Pinelli S et al (2019) Insights about urinary hippuric and citric acid as biomarkers of fruit and vegetable intake in patients with kidney stones: the role of age and gender. Nutrition 59:83–89CrossRef Guerra A, Ticinesi A, Allegri F, Nouvenne A, Prati B, Pinelli S et al (2019) Insights about urinary hippuric and citric acid as biomarkers of fruit and vegetable intake in patients with kidney stones: the role of age and gender. Nutrition 59:83–89CrossRef
32.
Zurück zum Zitat Meschi T, Nouvenne A, Ticinesi A, Prati B, Guerra A, Allegri F et al (2012) Dietary habits in women with recurrent idiopathic calcium nephrolithiasis. J Transl Med 10:63CrossRef Meschi T, Nouvenne A, Ticinesi A, Prati B, Guerra A, Allegri F et al (2012) Dietary habits in women with recurrent idiopathic calcium nephrolithiasis. J Transl Med 10:63CrossRef
33.
Zurück zum Zitat Ticinesi A, Milani C, Guerra A, Allegri F, Lauretani F, Nouvenne A et al (2018) Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers. Gut 67(12):2097–2106CrossRef Ticinesi A, Milani C, Guerra A, Allegri F, Lauretani F, Nouvenne A et al (2018) Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers. Gut 67(12):2097–2106CrossRef
34.
Zurück zum Zitat Guerra A, Ticinesi A, Allegri F, Nouvenne A, Pinelli S, Folesani G et al (2016) The influence of maternal and paternal history on stone composition and clinical course of calcium nephrolithiasis in subjects aged between 15 and 25. Urolithiasis 44(6):521–528CrossRef Guerra A, Ticinesi A, Allegri F, Nouvenne A, Pinelli S, Folesani G et al (2016) The influence of maternal and paternal history on stone composition and clinical course of calcium nephrolithiasis in subjects aged between 15 and 25. Urolithiasis 44(6):521–528CrossRef
35.
Zurück zum Zitat Guerra A, Ticinesi A, Allegri F, Nouvenne A, Pinelli S, Lauretani F et al (2017) Calcium urolithiasis course in young stone formers is influenced by the strength of family history: results from a retrospective study. Urolithiasis 45(6):525–533CrossRef Guerra A, Ticinesi A, Allegri F, Nouvenne A, Pinelli S, Lauretani F et al (2017) Calcium urolithiasis course in young stone formers is influenced by the strength of family history: results from a retrospective study. Urolithiasis 45(6):525–533CrossRef
36.
Zurück zum Zitat Jaggi M, Nakagawa Y, Zipperle L, Hess B (2007) Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function. Urol Res 35(2):55–62CrossRef Jaggi M, Nakagawa Y, Zipperle L, Hess B (2007) Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function. Urol Res 35(2):55–62CrossRef
37.
Zurück zum Zitat Yamate T, Tsuji H, Amasaki N, Iguchi M, Kurita T, Kohri K (2000) Analysis of osteopontin DNA in patients with urolithiasis. Urol Res 28(3):159–166CrossRef Yamate T, Tsuji H, Amasaki N, Iguchi M, Kurita T, Kohri K (2000) Analysis of osteopontin DNA in patients with urolithiasis. Urol Res 28(3):159–166CrossRef
38.
Zurück zum Zitat Rimel JD, Kolbach-Mandel AM, Ward MD, Wesson JA (2017) The role of macromolecules in the formation of kidney stones. Urolithiasis 45(1):47–54 Rimel JD, Kolbach-Mandel AM, Ward MD, Wesson JA (2017) The role of macromolecules in the formation of kidney stones. Urolithiasis 45(1):47–54
39.
Zurück zum Zitat Wollin DA, Kaplan AG, Preminger GM, Ferraro PM, Nouvenne A, Tasca A et al (2018) Defining metabolic activity of nephrolithiasis—appropriate evaluation and follow-up of stone formers. Asian J Urol 5(4):235–242CrossRef Wollin DA, Kaplan AG, Preminger GM, Ferraro PM, Nouvenne A, Tasca A et al (2018) Defining metabolic activity of nephrolithiasis—appropriate evaluation and follow-up of stone formers. Asian J Urol 5(4):235–242CrossRef
40.
Zurück zum Zitat Daudon M, Jungers P, Bazin D, Williams JC Jr. (2018) Recurrence rates of urinary calculi according to stone composition and morphology. Urolithiasis 46(5):459–470CrossRef Daudon M, Jungers P, Bazin D, Williams JC Jr. (2018) Recurrence rates of urinary calculi according to stone composition and morphology. Urolithiasis 46(5):459–470CrossRef
Metadaten
Titel
Idiopathic calcium nephrolithiasis with pure calcium oxalate composition: clinical correlates of the calcium oxalate dihydrate/monohydrate (COD/COM) stone ratio
verfasst von
Angela Guerra
Andrea Ticinesi
Franca Allegri
Silvana Pinelli
Rosalia Aloe
Tiziana Meschi
Publikationsdatum
10.09.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 3/2020
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-019-01156-8

Weitere Artikel der Ausgabe 3/2020

Urolithiasis 3/2020 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.